Cynata Therapeutics Limited (ASX:CYP) Releases Q1 2025 Activity Report
Cynata Therapeutics (ASX:CYP) reports progress in key clinical trials and maintains a strong financial position in Q1 2025.
Cynata Therapeutics (ASX:CYP) reports progress in key clinical trials and maintains a strong financial position in Q1 2025.
Perpetual Resources (ASX:PEC) reports exceptional high-grade lithium and caesium assays at the Igrejinha Project, preparing for its maiden drill campaign in June.
Raiz Invest (ASX:RZI) announces strong Q3 FY25 growth with increased active customers, ARPU, and Funds Under Management.
Livium Ltd (ASX:LIT) signs a A$5M recycling agreement with Sell & Parker, boosting its revenue and growth prospects.
Clime Investment Management Limited (ASX:CIW) declares a fully franked interim dividend and reports third quarter profit, highlighting operational enhancements.
Atomo Diagnostics Limited (ASX:AT1) completes a $3.1 million capital raise and announces a board restructure to enhance operational efficiency and drive growth.
Sandon Capital Investments Limited (ASX:SNC) declares a fully franked June quarter dividend of 1.4c per share, offering a 7.2% yield amid strong FY2025 returns.
PWR (ASX:PWH) announces the temporary leave of its Managing Director and the appointment of Matthew Bryson as Acting CEO.
Evion Group NL (ASX:EVG) secures community support for the Maniry Graphite Mine and advances toward final environmental approvals.
AusQuest Limited (ASX:AQD) announces Stage 2 Reverse Circulation drilling at its Cangallo project in Peru, with results expected in July 2025.